Sodium oxybate: A primer for pharmacists in the treatment off narcolepsy

Shana Castillo, Kimberley Begley, Mark Malesker, Chloe Steinshouer

Research output: Contribution to journalArticle

2 Scopus citations

Abstract

OBJECTIVE: The purpose of this report is to describe a 57-year-old man who was admitted to a nursing facility for physical therapy. His home medication list included sodium oxybate. This article will provide the pharmacist with a therapeutic overview of sodium oxybate as well as review the unique processes involved with drug acquisition, dosing, patient education, and monitoring. SETTING: Community pharmacy, nursing facility pharmacy, consultant pharmacy practice. PRACTICE CONSIDERATIONS: Sodium oxybate is the only medication in the United States that has approval for both treatment of cataplexy in narcolepsy and treatment of excessive daytime sleepiness in narcolepsy. Sodium oxybate has many unique properties that cause it to differ from past therapies for cataplexy and excessive daytime sleepiness associated with narcolepsy. CONCLUSION: It is important for pharmacists to understand the therapeutic uses of sodium oxybate and to review the processes for acquisition, dosing, and administration to better assist physicians and patients and improve therapeutic outcomes.

Original languageEnglish (US)
Pages (from-to)547-554
Number of pages8
JournalConsultant Pharmacist
Volume29
Issue number8
DOIs
StatePublished - Aug 1 2014

All Science Journal Classification (ASJC) codes

  • Pharmacology (medical)

Fingerprint Dive into the research topics of 'Sodium oxybate: A primer for pharmacists in the treatment off narcolepsy'. Together they form a unique fingerprint.

  • Cite this